Cross Linked Deep Type Hyaluronic Acid
Ingredient: 24mg/m hyaluronic acid
Specification: 1ml, 2ml, 3ml, 5ml, 10ml, 20ml, 50ml
Package: Syringe
Recommended use: 1-3 pcs, 12 months apart
Application Area: Chin, nasal dorsum, nasal column and anterior nose
Product Introduction:
The HA gel portfolio features process-differentiated solutions: Tissue-integrating single gels for natural contours and high-lift double formulations requiring low injection force. With Super-grade D24+ lasting 9-12 months clinically, our products outpace American equivalents in persistence. Micro-crosslinked D12 demonstrates 92% patient satisfaction in fine wrinkle correction, while HD20's antioxidant formula reduces post-lip augmentation edema by 37% versus standard D20.
Product Display:
Product Details:
Type | Deep |
Ingredient | Cross Linked Hyaluronic Acid Dermal Filler |
Specification | 1ml, 2ml, 3ml, 5ml, 10ml, 20ml, 50ml |
Cross Link | BDDE chemical cross link |
Texture | Gel |
Elasticity | 500 Pa-650 Pa |
Viscosity | 150 Pa-250 Pa |
Mean particle size | 400μm-600μm |
Effective content | 24mg/mL |
Cross linker residue | No,or≤0.5ug/g |
Protein residue | ≤20μg/g |
Endotoxin content | <0.5EU/mL |
Swelling degree | 20-40 |
Extruding force | 20N-30N |
Application area | Chin, nasal dorsum, nasal column and anterior nose |
Package | Syringe |
Stoarge | Room temperature (1-25ºC), cool and dry place |
Recommended | 1-3 pcs (vary with each individual |
Recommended interval | 12 month |
Product Package:
Customer Feedback:
Raw Material Advantages:
1. In cosmetic formulations, CLHA maintains efficacy in high-humidity environments where linear HA would absorb excess moisture.
2. Cross-linked networks facilitate ionic binding of growth factors like TGF-β for localized regenerative therapies.
3. CLHA fillers with heterogeneous particle sizes enable multi-layered tissue augmentation strategies.
Development Process:
Company Introduction:
A leader in biomedical innovation since 2014, Jinan Grandwill develops implant-grade materials and medical cosmetics through advanced R&D. Our 5,000-sqm production base features 6 specialized lines, including prefilled syringes and high-pressure sterilization systems. With 7 invention patents and 4 utility models, our ISO 9001-certified processes ensure chemical purity, stability, and compliance with global safety standards.